---
title: "Lisinopril 10 mg tablets, 30-count Blister Card, Rx Only, MFG: Lupin Pharma, ... — FDA record D-1538-2022 | Is It on Recall"
description: "Presence of Foreign Substance: Foreign material (metal piece) embedded in one tablet."
url: https://isitonrecall.com/recall/fda-drug-d-1538-2022-lisinopril-10-mg-tablets-30-count-blister-card-rx-only-mfg-lupin-pharma-baltimore-md-repackaged-by-r/
updated: 2026-10-01
site: "Is It on Recall"
language: en
---

[Recall archive](https://isitonrecall.com/archives/) / FDA drug enforcement

# Lisinopril 10 mg tablets, 30-count Blister Card, Rx Only, MFG: Lupin Pharma, Baltimore, MD Repackaged by: RemedyRepac... — FDA record D-1538-2022

Reported terminated

Status as reported in the agency record. FDA warns that enforcement status may not track the current recall lifecycle; check the current official notice.

Source date Sep 15, 2022. Retrieved Oct 1, 2026. Last updated Oct 1, 2026.

Archive changed Oct 1, 2026. USDA FSIS records are unavailable; [check FSIS directly](https://www.fsis.usda.gov/recalls). [Source coverage and dates](https://isitonrecall.com/sources/).

## What the record says

- **Product**: Lisinopril 10 mg tablets, 30-count Blister Card, Rx Only, MFG: Lupin Pharma, Baltimore, MD Repackaged by: RemedyRepack Inc, Indiana PA. Original NDC# 68180-0980-03, Repackaged NDC# 70518-0468-00
- **Reason**: Presence of Foreign Substance: Foreign material (metal piece) embedded in one tablet.
- **Classification**: Class II
- **Recalling firm**: RemedyRepack Inc.
- **Quantity**: 1,699 blister cards/30 tablets each
- **Agency-reported status**: Terminated
- **Source record identifier**: D-1538-2022

[Open the official record](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-1538-2022%22)

[What the recall classes mean](https://isitonrecall.com/guides/recall-classes/). Classification is an agency assessment, not individual medical advice.

## Lot and product identifiers

| Label field | Details supplied by the agency |
| --- | --- |
| Lot, code or applicability | Lot # J0636336-073022, J0637605-080422, Exp. date 08/31/2023 |

Match all identifying details in the current notice. A brand name alone is not enough.

## Distribution

Distributed to two direct accounts in PA and AK.

States below are derived from the distribution text, including nationwide wording. They are not inferred from the firm's address.

- [Alaska](https://isitonrecall.com/state/alaska/)
- [Pennsylvania](https://isitonrecall.com/state/pennsylvania/)

## Dates in the source

- **Report date**: Sep 21, 2022
- **Recall initiation date**: Sep 15, 2022
- **Center classification date**: Sep 15, 2022
- **Termination date**: Nov 16, 2022

FDA company pages use the listing date; enforcement records use initiation dates; CPSC uses recall date; NHTSA uses report-received date. These dates are not interchangeable.

## What to do next

Read the official notice for the action that applies to your exact product.

[Read the current instructions](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-1538-2022%22)

## Before changing a medicine

Follow urgent instructions in the current official recall notice. Speak to your pharmacist or prescriber before stopping or changing a prescribed medicine.

Talk to your doctor or pharmacist if you have questions or concerns about your medicine. [FDA medication recall guidance](https://www.fda.gov/drugs/drug-recalls/understanding-drug-recalls-what-know-and-what-do)

## Related records

[Lisinopril records](https://isitonrecall.com/drug/lisinopril/) [Medications records](https://isitonrecall.com/category/medications/) [RemedyRepack Inc. records](https://isitonrecall.com/brand/remedyrepack-inc/)